6-36676733-A-G

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The NM_001291549.3(CDKN1A):​c.-142+163A>G variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.218 in 151,930 control chromosomes in the GnomAD database, including 4,471 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.22 ( 4471 hom., cov: 32)

Consequence

CDKN1A
NM_001291549.3 intron

Scores

2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: -0.392

Publications

5 publications found
Variant links:
Genes affected
CDKN1A (HGNC:1784): (cyclin dependent kinase inhibitor 1A) This gene encodes a potent cyclin-dependent kinase inhibitor. The encoded protein binds to and inhibits the activity of cyclin-cyclin-dependent kinase2 or -cyclin-dependent kinase4 complexes, and thus functions as a regulator of cell cycle progression at G1. The expression of this gene is tightly controlled by the tumor suppressor protein p53, through which this protein mediates the p53-dependent cell cycle G1 phase arrest in response to a variety of stress stimuli. This protein can interact with proliferating cell nuclear antigen, a DNA polymerase accessory factor, and plays a regulatory role in S phase DNA replication and DNA damage repair. This protein was reported to be specifically cleaved by CASP3-like caspases, which thus leads to a dramatic activation of cyclin-dependent kinase2, and may be instrumental in the execution of apoptosis following caspase activation. Mice that lack this gene have the ability to regenerate damaged or missing tissue. Multiple alternatively spliced variants have been found for this gene. [provided by RefSeq, Sep 2015]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.84).
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.407 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
CDKN1ANM_001291549.3 linkc.-142+163A>G intron_variant Intron 1 of 3 NP_001278478.1
CDKN1ANM_001374509.1 linkc.-50+163A>G intron_variant Intron 1 of 3 NP_001361438.1
CDKN1ANM_001374510.1 linkc.34+163A>G intron_variant Intron 1 of 2 NP_001361439.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
CDKN1AENST00000448526.6 linkc.-38+209A>G intron_variant Intron 1 of 3 3 ENSP00000409259.3
CDKN1AENST00000615513.4 linkc.-6+209A>G intron_variant Intron 1 of 2 2 ENSP00000482768.1
CDKN1AENST00000459970.1 linkn.43+163A>G intron_variant Intron 1 of 2 5

Frequencies

GnomAD3 genomes
AF:
0.218
AC:
33127
AN:
151814
Hom.:
4456
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.330
Gnomad AMI
AF:
0.143
Gnomad AMR
AF:
0.322
Gnomad ASJ
AF:
0.0956
Gnomad EAS
AF:
0.423
Gnomad SAS
AF:
0.122
Gnomad FIN
AF:
0.119
Gnomad MID
AF:
0.156
Gnomad NFE
AF:
0.142
Gnomad OTH
AF:
0.219
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.218
AC:
33186
AN:
151930
Hom.:
4471
Cov.:
32
AF XY:
0.219
AC XY:
16266
AN XY:
74234
show subpopulations
African (AFR)
AF:
0.330
AC:
13654
AN:
41386
American (AMR)
AF:
0.322
AC:
4925
AN:
15278
Ashkenazi Jewish (ASJ)
AF:
0.0956
AC:
332
AN:
3472
East Asian (EAS)
AF:
0.422
AC:
2179
AN:
5164
South Asian (SAS)
AF:
0.122
AC:
588
AN:
4818
European-Finnish (FIN)
AF:
0.119
AC:
1252
AN:
10526
Middle Eastern (MID)
AF:
0.156
AC:
46
AN:
294
European-Non Finnish (NFE)
AF:
0.142
AC:
9621
AN:
67978
Other (OTH)
AF:
0.218
AC:
459
AN:
2104
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
1213
2426
3640
4853
6066
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
322
644
966
1288
1610
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.183
Hom.:
425
Bravo
AF:
0.246
Asia WGS
AF:
0.251
AC:
873
AN:
3478

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.84
CADD
Benign
1.6
DANN
Benign
0.64
PhyloP100
-0.39
PromoterAI
-0.0018
Neutral

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs3829965; hg19: chr6-36644510; API